LinkedIn Profile

Access Stentys historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:stentys 583279 Jul 10th, 2020 12:00AM STENTYS 3.0K 28.00 Open Medical Device Jul 9th, 2020 08:53PM Jul 9th, 2020 08:53PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Jul 8th, 2020 12:00AM STENTYS 3.0K 28.00 Open Medical Device Jul 7th, 2020 08:31PM Jul 8th, 2020 06:33PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Jul 7th, 2020 12:00AM STENTYS 2.9K 28.00 Open Medical Device Jul 6th, 2020 08:26PM Jul 6th, 2020 08:26PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Jul 5th, 2020 12:00AM STENTYS 3.0K 27.00 Open Medical Device Jul 4th, 2020 08:07PM Jul 5th, 2020 07:58PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Jul 3rd, 2020 12:00AM STENTYS 3.0K 27.00 Open Medical Device Jul 3rd, 2020 02:06PM Jul 3rd, 2020 02:06PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Jul 2nd, 2020 12:00AM STENTYS 2.9K 28.00 Open Medical Device Jul 2nd, 2020 07:57PM Jul 2nd, 2020 07:57PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Jul 1st, 2020 12:00AM STENTYS 2.9K 28.00 Open Medical Device Jun 30th, 2020 08:12PM Jul 1st, 2020 06:34PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Jun 29th, 2020 12:00AM STENTYS 2.9K 29.00 Open Medical Device Jun 28th, 2020 08:01PM Jun 29th, 2020 02:36PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Jun 27th, 2020 12:00AM STENTYS 2.9K 29.00 Open Medical Device Jun 27th, 2020 05:25PM Jun 27th, 2020 05:25PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Jun 26th, 2020 12:00AM STENTYS 2.9K 29.00 Open Medical Device Jun 26th, 2020 05:59PM Jun 26th, 2020 05:59PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.